Small-Molecule Targeted Cancer Therapies Market Set to See Strong Revenue Growth, According to Visiongain

04 Feb 2013 • by Natalie Aster

Revenue predictions to 2023 can be found in the updated report “Small-Molecule Targeted Cancer Therapies: World Market 2013-2023” by Visiongain. There you find sales data, R&D trends, opportunities and commercial prospects.

You see the potential of those molecularly-targeted technologies and products. The new analysis lets you assess forecasted sales at overall world market, product and national level.

There are revenue forecasting to 2023, historical data, growth rates and market shares in this study. Also, you see qualitative analysis (SWOT and STEP), business news, outlooks and developmental trends (R&D). You gain 72 tables, 34 charts and four research interviews.

Report Details:

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023
Published: December, 2012
Pages: 174
Price: US$ 2,497.00

Overall world revenue for that market area will reach $32.7bn in 2016, the report forecasts. The study predicts strong revenue growth to 2023, owing to rising demand for anti-cancer medicines. Rising disease incidence and prevalence will stimulate market growth.

More information can be found in the report “Small-Molecule Targeted Cancer Therapies: World Market 2013-2023” by Visiongain.

To order the report or ask for sample pages contact ps@marketpublishers.com

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com